DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sulkowski MS, Kang M, Matining R. et al; AIDS Clinical Trials Group A5277 Protocol Team.
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.
J Infect Dis 2014;
209 (05) 658-667
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.